Targeted Genome Modifications Using Integrase‐deficient Lentiviral Vectors
Open Access
- 1 December 2007
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (12), 2107-2113
- https://doi.org/10.1038/sj.mt.6300345
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1Nature Medicine, 2006
- Gene targeting using zinc finger nucleasesNature Biotechnology, 2005
- Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vectorThe Lancet, 2004
- Human Gene Targeting by Adeno-Associated Virus Vectors Is Enhanced by DNA Double-Strand BreaksMolecular and Cellular Biology, 2003
- Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative ConditioningScience, 2002
- Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene TherapyNew England Journal of Medicine, 2002
- Human gene targeting by viral vectorsNature Genetics, 1998
- Induction of Homologous Recombination in Mammalian Chromosomes by Using the I-SceI System of Saccharomyces cerevisiaeMolecular and Cellular Biology, 1995
- Double-strand breaks at the target locus stimulate gene targeting in embryonic stem cellsNucleic Acids Research, 1995
- Expression of a site-specific endonuclease stimulates homologous recombination in mammalian cells.Proceedings of the National Academy of Sciences, 1994